CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Gilead Sciences signs five-year DevOps agreement with Cognizant

PartnershipNeutral
AI Analysis

Summary

Gilead Sciences extended its five-year agreement with Cognizant to enhance DevOps capabilities and support deployment of agentic AI tools across technology initiatives.

Importance:2/10
Sentiment:
0.20
partnershipDevOpsAItechnology
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 7, 2026 7:21 AM

Read Original